NEA Management Company, LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 92 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$66,710,741
+39.0%
2,909,9560.0%5.15%
+40.6%
Q2 2023$47,985,174
-7.6%
2,909,9560.0%3.66%
+2.1%
Q1 2023$51,913,615
-63.7%
2,909,956
-40.7%
3.59%
-55.3%
Q4 2022$142,977,919
+32.0%
4,909,956
-0.0%
8.04%
+48.6%
Q3 2022$108,316,000
+431.3%
4,912,3060.0%5.41%
+416.4%
Q2 2022$20,386,000
-64.0%
4,912,3060.0%1.05%
-36.0%
Q1 2022$56,590,000
+15.4%
4,912,3060.0%1.64%
+65.0%
Q4 2021$49,025,000
-23.6%
4,912,3060.0%0.99%
+30.1%
Q3 2021$64,155,000
-33.3%
4,912,3060.0%0.76%
-39.2%
Q2 2021$96,183,000
-7.9%
4,912,3060.0%1.25%
-46.6%
Q1 2021$104,485,000
-26.9%
4,912,3060.0%2.34%
-37.9%
Q4 2020$142,948,000
+34.3%
4,912,3060.0%3.77%
-16.3%
Q3 2020$106,450,000
-2.8%
4,912,3060.0%4.51%
+2.3%
Q2 2020$109,544,000
+46.5%
4,912,3060.0%4.40%
+12.7%
Q1 2020$74,765,000
-33.7%
4,912,3060.0%3.91%
-26.8%
Q4 2019$112,787,000
+6.3%
4,912,3060.0%5.33%
-39.3%
Q3 2019$106,057,000
-1.9%
4,912,3060.0%8.78%
+16.0%
Q2 2019$108,071,000
-19.7%
4,912,3060.0%7.57%
+8.3%
Q1 2019$134,646,000
+2.0%
4,912,3060.0%6.99%
+33.5%
Q4 2018$132,043,000
-7.9%
4,912,3060.0%5.24%
-15.3%
Q3 2018$143,292,000
-6.7%
4,912,3060.0%6.18%
-14.1%
Q2 2018$153,559,000
+57.1%
4,912,3060.0%7.19%
+65.5%
Q1 2018$97,755,000
-31.5%
4,912,3060.0%4.35%
-26.5%
Q4 2017$142,752,0004,912,3065.91%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders